At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
PRFX PainReform
Trading 11-21 13:26:25 EST
3.30
-0.86
-20.79%
High3.90
Low3.00
Vol363.81K
Open3.31
D1 Closing4.16
Amplitude21.63%
Mkt Cap7.34M
Tradable Cap7.28M
Total Shares2.23M
T/O1.25M
T/O Rate16.48%
Tradable Shares2.21M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
PainReform (PRFX) Receives a Hold from Maxim Group
PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. The company engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. It is currently conducting Phase 3 clinical trials of PRF-110 for the treatment of patients undergoing bunionectomy surgery and hernia repair. The company was incorporated in 2007 and is based in Tel Aviv, Israel.